IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.645
AS - Asia 17.859
EU - Europa 14.506
SA - Sud America 4.426
AF - Africa 525
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 22
Totale 66.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.367
SG - Singapore 6.969
RU - Federazione Russa 4.953
CN - Cina 4.510
BR - Brasile 3.458
IT - Italia 3.023
VN - Vietnam 2.557
GB - Regno Unito 1.768
HK - Hong Kong 1.380
DE - Germania 1.101
CA - Canada 821
FR - Francia 655
FI - Finlandia 535
UA - Ucraina 470
IE - Irlanda 455
IN - India 425
AR - Argentina 347
MX - Messico 318
SE - Svezia 315
BD - Bangladesh 290
TR - Turchia 281
NL - Olanda 268
PL - Polonia 249
ID - Indonesia 215
ZA - Sudafrica 195
ES - Italia 185
IQ - Iraq 181
EC - Ecuador 176
IL - Israele 171
JP - Giappone 165
PK - Pakistan 155
CO - Colombia 115
AT - Austria 108
VE - Venezuela 90
MA - Marocco 86
UZ - Uzbekistan 76
DK - Danimarca 72
AE - Emirati Arabi Uniti 71
LT - Lituania 63
PY - Paraguay 63
CL - Cile 60
SA - Arabia Saudita 54
EG - Egitto 53
TN - Tunisia 46
PE - Perù 45
KE - Kenya 44
CH - Svizzera 38
PH - Filippine 37
BE - Belgio 34
MY - Malesia 33
AU - Australia 32
UY - Uruguay 32
JO - Giordania 31
BO - Bolivia 30
AZ - Azerbaigian 29
DZ - Algeria 29
RO - Romania 25
CR - Costa Rica 23
CZ - Repubblica Ceca 23
KZ - Kazakistan 22
DO - Repubblica Dominicana 20
OM - Oman 19
EU - Europa 17
IR - Iran 17
AL - Albania 16
TH - Thailandia 16
LB - Libano 15
NP - Nepal 15
TW - Taiwan 15
PA - Panama 14
SK - Slovacchia (Repubblica Slovacca) 14
HN - Honduras 13
JM - Giamaica 13
NI - Nicaragua 13
PT - Portogallo 13
AM - Armenia 12
ET - Etiopia 12
KG - Kirghizistan 12
BG - Bulgaria 11
GR - Grecia 11
GT - Guatemala 11
NZ - Nuova Zelanda 11
PS - Palestinian Territory 11
GE - Georgia 10
RS - Serbia 10
TT - Trinidad e Tobago 10
CI - Costa d'Avorio 9
HR - Croazia 9
HU - Ungheria 9
KR - Corea 9
LV - Lettonia 9
SN - Senegal 9
BH - Bahrain 8
BY - Bielorussia 8
GY - Guiana 8
MC - Monaco 8
NO - Norvegia 8
SI - Slovenia 8
BB - Barbados 7
CG - Congo 7
Totale 65.889
Salva come PNG Salva come JPEG
Città #
Dallas 6.195
Singapore 3.680
Ashburn 2.113
San Jose 2.078
Beijing 1.724
Chicago 1.446
Hong Kong 1.305
Los Angeles 1.261
Moscow 916
Ho Chi Minh City 833
Salt Lake City 610
Chandler 562
Southend 543
Hanoi 494
The Dalles 469
Fairfield 462
Buffalo 452
San Mateo 451
Dublin 446
New York 443
Houston 399
Lauterbourg 360
São Paulo 359
Woodbridge 359
Wilmington 355
Hefei 353
Tampa 346
Helsinki 334
Santa Clara 330
Cambridge 321
Seattle 307
Milan 304
Council Bluffs 271
Elk Grove Village 270
Boardman 256
Portsmouth 242
Rome 242
Falls Church 237
Munich 235
Warsaw 216
Stevenage 215
Pisa 213
Ann Arbor 212
Orem 207
Ottawa 206
Beauharnois 193
Montreal 187
Jacksonville 183
Brooklyn 164
Florence 163
London 159
Frankfurt am Main 158
Mexico City 157
Dearborn 156
Lawrence 155
Istanbul 148
Tel Aviv 148
Tokyo 145
Sterling 133
Denver 130
Stockholm 130
Poplar 128
Chennai 126
Lancaster 126
Johannesburg 124
Amsterdam 121
Rio de Janeiro 118
Dong Ket 117
Nuremberg 113
Phoenix 108
Atlanta 107
Lappeenranta 107
Da Nang 105
Toronto 104
Miami 101
Haiphong 97
Boston 91
Belo Horizonte 86
Dulles 79
Manchester 71
Biên Hòa 70
Turku 70
San Diego 69
Tashkent 66
Ankara 64
Bologna 61
Brasília 61
Mumbai 61
Quito 61
San Francisco 60
Curitiba 59
Guangzhou 59
Washington 58
Baghdad 57
Naples 57
Guayaquil 56
Detroit 55
Porto Alegre 55
Genoa 54
Campinas 51
Totale 39.374
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.832
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.674
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.565
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 870
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 698
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 597
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 443
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 406
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 395
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 360
A simple echocardiographic score to rule out cardiac amyloidosis 359
Building medical knowledge from real world registries: The case of heart failure 343
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 338
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 335
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 326
A simple echocardiographic score to rule out cardiac amyloidosis 325
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 323
Treating chemoreflex in heart failure: modulation or demolition? 321
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 320
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 311
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 309
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 301
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 298
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 298
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 293
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 279
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 279
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 279
[Ten perspectives for research and innovation in cardiac amyloidosis] 277
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 277
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 276
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 275
Sex-related differences in chronic heart failure 274
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 273
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 271
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 270
How to take arms against central apneas in heart failure 268
Screening the health status of people working in a university 267
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 266
Cardiac light-chain deposition disease relapsing in the transplanted heart 265
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 260
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 258
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 257
Unmet needs in end-of-life care for heart failure patients 256
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 256
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 256
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 255
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 254
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 252
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 251
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 250
Atrial amyloidosis: mechanisms and clinical manifestations 248
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 247
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 247
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 246
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 242
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 242
Biomarkers for the diagnosis and management of heart failure: New frontiers 242
Eligibility for vericiguat in a real‐world, contemporary heart failure population 241
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 241
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 240
RNA-targeting and gene editing therapies for transthyretin amyloidosis 239
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 239
Biomarkers for the diagnosis and management of heart failure 237
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 236
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 236
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 233
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 232
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 230
Role of Imaging in Cardiomyopathies 228
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 227
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 227
Cardiac troponins as biomarkers for cardiac disease 225
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 224
Cardiac magnetic resonance in patients with muscular dystrophies 224
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 224
Cardiovascular disease and COVID-19: les liaisons dangereuses 221
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 220
Disease features and management of cardiomyopathies in women 220
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 219
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 219
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 219
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 218
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 216
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 215
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 215
Perspectives in noninvasive imaging for chronic coronary syndromes 213
Amiodarone as a possible therapy for coronavirus infection 212
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient 212
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 212
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 211
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 211
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 209
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 209
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 207
Valvular heart disease in patients with cardiac amyloidosis 206
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 205
Cardiac amyloidosis: Innovations in diagnosis and treatment 204
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets 204
Tissue Characterization in Cardiac Amyloidosis 203
Totale 31.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 320.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 320.507
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021731 0 0 0 0 0 0 0 0 0 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202636.690 2.194 6.182 4.866 5.533 4.011 2.661 4.125 1.997 2.695 2.426 0 0
Totale 66.458